A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Glycopyrrolate


Excessive sweating is an illness  -  May 16, 2007
DetNews.com,A reader wrote to me that his life was changed by Robinul Forte (glycopyrrolate). Glycopyrrolate can be made into a 5 percent solution to be put on the skin

Answers for Millions Who Suffer From Excessive Perspiration  -  May 4, 2007
Hispanic PR Wire (press release),Oral Medications: An oral glycopyrrolate may be effective in reducing excessive perspiration, but can lead to dryness of the mouth and blurred vision.

Sciele Pharma, Inc. Reports Results for the First Quarter of 2007  -  Apr 27, 2007
PharmaLive.com (press release),This increase was primarily due to the product development costs associated with the new Sular formulation and glycopyrrolate for chronic,

Role of Atropine and Glycopyrrolate in Organophosphate Poisoning ...  -  Apr 24, 2007
AEM (subscription)Patients with OP poisoning received either atropine and glycopyrrolate or atropine and matching placebo as a bolus through a peripheral IV line.

Alliant to become part of Sciele  -  Apr 25, 2007
San Antonio Business Journal,...and will enable us to maximize the potential of glycopyrrolate, a Sciele product that is in pivotal phase III clinical trials for pediatric chronic,

Sciele Pharma Begins Pivotal Phase III Safety Trial for Glycopyrrolate  -  Apr 3, 2007
PharmaLive.com (press release),Glycopyrrolate received orphan drug designation from the FDA in June of 2006. The FDA orphan drug designation is intended to provide incentives to encourage

Sciele Pharma Begins Pivotal Phase III Safety Trial for Glycopyrrolate  -  Apr 3, 2007
Genetic Engineering News (press release),Sciele Pharma, Inc. (NASDAQ:SCRX) today announced that it has begun enrolling patients in a pivotal phase III safety trial utilizing glycopyrrolate to treat

Sciele Pharma to start glycopyrrolate trial  -  Apr 3, 2007
Atlanta Business Chronicle,...with the Food and Drug Administration in the middle of 2008 and launch the product, glycopyrrolate, in the middle of 2009 after FDA approval.

Market Report -- In Play (SCRX)  -  Apr 3, 2007
MSN MoneySciele Pharma begins pivotal phase III safety trial for Glycopyrrolate Co announces it has begun enrolling patients in a pivotal phase III safety trial

Sciele Pharma begins enrollment in Ph II  -  Apr 5, 2007
Therapeutics Daily (subscription) (press release),Glycopyrrolate is a developmental anticholinergic that received Orphan Drug designation for pediatric drooling from the Food and Drug Administration last

ECT in Patients With Intracranial Masses  -  Apr 12, 2007
Journal of Neuropsychiatry (subscription)Anesthesia technique included glycopyrrolate as antisialogogue, thiopental for induction, and succinylcholine for neuromuscular blockade.

Business Briefs: Temple-Inland Spinoff to Focus on Atlanta Real ...  -  Feb 27, 2007
GoDeKalb.com (press release),...and the product development costs associated with the new Sular formulation and glycopyrrolate for pediatric chronic moderate to severe drooling.

Sciele Pharma, Inc. Reports Results for the Fourth Quarter and ...  -  Feb 23, 2007
PharmaLive.com (press release),This increase was primarily due to the product development costs associated with the new Sular formulation and glycopyrrolate for pediatric chronic moderate

Sciele Expects 2007 Profit Jump  -  Feb 22, 2007
Houston Chronicle,Phase III clinical trials for a pravastatin-fenofibrate combination and glycopyrrolate are also included in the outlook with the launch of a new formulation

BUY ALTACE, Altace Online, Altace Cheap  -  Dec 25, 2006
Indymedia Colombia,For glycopyrrolate injection (Robinul), side affects zyban ramipril prescribing error zyban capsules (Altace), and war be made by.

BUY ALTACE, Altace Online, Altace Cheap  -  26 Dec 2006
Indymedia Colombia,For glycopyrrolate injection (Robinul), side affects zyban ramipril prescribing error zyban capsules (Altace), and war be made by.

Sciele Pharma, Inc. Reports Results for the Third Quarter 2006  Oct 26, 2006
...was primarily due to an increase in the Company's product development initiatives, which include the new Sular formulation and glycopyrrolate for chronic ... -Genetic Engineering News (press release), RMTC Addresses Future Plans; Retains Gallagher as Consultant  Nov 3, 2006
...soon complete a pilot project on eight therapeutic medications: acepromazine, lidocaine, mepivacaine, pyrilamine, glycopyrrolate, butorphanol, methacarbomol ... -BloodHorse, Sciele Pharma up 16%  Oct 27, 2006
...was primarily due to an increase in the company's product development initiatives, which include the new Sular formulation and glycopyrrolate for chronic ... -Atlanta Business Chronicle, Sciele Pharma, Inc. Reports Revenues and Earnings for the Second ...  Jul 26, 2006
We recently received orphan drug designation from the FDA for glycopyrrolate to treat chronic moderate- to-severe drooling in pediatric patients. ... -Genetic Engineering News

Sciele Pharma profit jumps 27.5%  Jul 30, 2006
Fourteau further noted the company received orphan drug designation from the FDA in June for glycopyrrolate to treat chronic moderate- to-severe drooling in ... -Bizjournals.com

Life-changing group to convene in Salt Lake  Jun 26, 2006
Attending an Oley conference four years ago, Davis learned he could reduce his saliva production with a prescription drug called Glycopyrrolate. ... -Salt Lake Tribune



Breathe Easier!  Jan 22, 2006
Glycopyrrolate, a cousin to atropine, is also administered intravenously, but has fewer side effects and can be administered once or twice during an acute ... - TheHorse.com


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional